Gamma Glutamylcysteine Treatment or Prevention of Oxidative Injury
OwnerMarshall Summar, Gary Cunningham +4inventors
InventorsMarshall Summar, Gary Cunningham, Michael Aschner, Truc Le, Rick Barr, Paul Moore
Life of this patent
Estimating the term…
Abstract
The present invention concerns the γ-glutamylcysteine treatment to reduce oxidative damage caused by ischemia/reperfusion events such as pulmonary hypertension, transplant, cardiac bypass and other surgeries, and trauma. In specific embodiments, preservation methods and apparatuses for preserving tissue for transplantation purposes is provided.
Claims16
A method of preventing or ameliorating oxidative injury to a cell comprising contacting said cell with a composition comprising γ-glutamylcysteine (GGC).
A method of protecting a subject from oxidative injury comprising administering to said subject a pharmaceutical composition comprising γ-glutamylcysteine (GGC).
Dependencies are inferred from the claim text.